The Antibacterials Market Outlook to 2016

Date: May 22, 2011
Pages: 96
Price:
US$ 3,835.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AA41EE2D522EN
Leaflet:

Download PDF Leaflet

The Antibacterials Market Outlook to 2016
Price
Global License: US$ 14,780.00


Introduction

This report provides comprehensive coverage of the global antibacterials market, incorporating disease overview, epidemiological analyses of the major indications, market dynamics. Resistors and drivers are examined along with the most promising areas of growth. Current leading antibacterial brands are assessed and five of the market’s leading players are profiled.

Features and benefits
  • Assess the forecast epidemiology and development of the antibacterials market across the 7MM.
  • Analyze the dynamics of the global antibacterials market and understand the impact of key R&D events, market trends, and issues.
  • Gain up-to-date competitive intelligence and understand the major issues affecting key pharmaceutical marketers and product development.
  • Predict revenues for major currently marketed and pipeline antibacterial products over 2010–16
  • Develop strategies for success in the future antibacterial market.
Highlights

Of the competing drug classes in global antibacterials market, cephalosporins occupied the leading position with over 25% share followed by penicillins and fluoroquinolones. However, all these drug classes declined in sales in 2010.

Despite high patient numbers, the cost and complexities coupled with regulatory uncertainties and challenges have shifted the investment focus of pharmaceutical manufacturers from antibacterials to treatments for chronic conditions.

Community acquired pneumonia (CAP) and hospital acquired pneumonia (HAP) infections are attracting research interest. Additionally, the majority of companies developing new antibiotics are targeting cell wall synthesis inhibitors, DNA topoisomerase II inhibitors, ribosomal inhibitors and methionine tRNA ligase inhibitors.

Your key questions answered
  • What are the drivers and resistors of the antibacterials market worldwide?
  • What market and pipeline developments are shaping the strategies of leading pharmaceutical companies in the antibacterials market?
  • What is the forecast commercial potential of the most promising compounds in clinical development?
  • Who were the leading players in the global antibacterials market in 2010?
  • How have recent launches from companies such as GSK, Pfizer, J&J, Novartis and Merck & Co. performed?
Executive Summary
  Disease overview and epidemiology
  Global market analysis
  Pipeline analysis
  Competitive landscape
About the author
  Disclaimer
Disease overview and epidemiology
  Summary
  Introduction
    Bacterial infections
    Diagnosis, treatment and management
    Epidemiology of bacterial infections
    Forecast epidemiology
Global market analysis
  Summary
  Introduction
    Market dynamics
    Leading brands dynamics
    Resistors of the antibacterial market
    Drivers of the antibacterial market
    Global antibacterial market sales forecast
Pipeline analysis
  Summary
  Introduction
  Antibacterial pipeline
  Key events in antibacterial R&D
    Cubist settles patent infringement litigation with Teva over Cubicin
    Merck & Co. intends to strengthen antibacterial research through BioRelix
    GSK exercises its option with Anacor to commercialize GSK2251052
    Zeftera withdrawn following concerns raised by the FDA and the EMA
    Durata Therapeutics initiates Phase III trials for dalbavancin
  Leading drugs in development
    Profiles of key pipeline products
  Pipeline forecast to 2016
Competitive landscape
  Summary
  Introduction
  GlaxoSmithKline
    Overview
    Financial performance
    Marketed product portfolio
    Research and development
    Strategic and growth analysis
  Pfizer
    Overview
    Financial performance
    Marketed product portfolio
    Research & development
    Strategic and growth analysis
  Johnson & Johnson
    Overview
    Financial performance
    Marketed product portfolio
    Research & development
    Strategic and growth analysis
  Merck & Co.
    Overview
    Financial performance
    Marketed product portfolio
    Research & development
    Strategic and growth analysis
  Novartis
    Overview
    Financial performance
    Marketed product portfolio
    Research & development
    Strategic and growth analysis
Appendix
  Scope
  Market size methodology
  Epidemiology
  Market forecast
  Abbreviations
Skip to top


Hand Sanitizers: Market Research Report US$ 4,950.00 Jan, 2015 · 230 pages

Ask Your Question

The Antibacterials Market Outlook to 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: